Dr. Sarita Srivastava

Dr. Sarita Shrivastva is a Medical Oncologist and has an experience of 14 years in this field. She completed MBBS from Dr. NTR University of Health Sciences Andhra Pradesh in 2010.

Some of the services provided by the doctor are: Chemotherapy of Solid Tumors,Chemotherapy of Haematological Malignancies and Stem Cell Transplantation etc.

Expertise :

• Brain tumors
• Head and neck cancers
• Thyroid cancers
• Lung cancers
• Breast cancer
• Thymic tumors
• Esophageal cancers
• Stomach cancers
• Liver cancer
• Biliary and pancreatic cancer
• Colorectal cancers
• Ovarian cancers
• Uterine cancers
• Cervical cancers
• Kidney cancer
• Bladder cancer
• Prostate cancer
• Testicular tumors
• Sarcoma
• Lymphoma
• Leukemia
• Multiple myeloma
• Melanoma and other skin cancers
• Targeted therapy
• Immunotherapy
• Hormonal therapy
• Bone marrow transplantation
• Cancer screening
• Genetic counselling and management of hereditary cancers
• Pain, palliative and supportive care
• Second opinion

Past Experience :

• Worked as Consultant Medical and hemato oncologist at Cion cancer clinics

Awards & Achievements :

• Winner of 42nd National Level ICON Quiz, Mar’ 20, Hyderabad
• Winner of 41st National Level ICON Quiz, Sep’19, Ahmedabad
• Winner of 40th National Level ICON Quiz, Mar’19, Kolkata
• Winner in Poster Presentation in National
• Conference of ISMPOCON, 2018, Jaipur

Presentations At National & International Conferences :

• Is exon 19 deletion different from exon 21 mutation in advanced non-small cell lung cancer: a single center experience – ESMO ASIA, SINGAPORE, NOVEMBER 2019
• Trastuzumab related cardiotoxicity in nonmetastatic breast cancer: a real-world scenario – ESMO BREAST CANCER ANNUAL CONGRESS, BERLIN, GERMANY 2019
• Clinico-pathological profile, treatment and outcomes of metastatic gastric cancer: an institutional experience – 40TH ICON CONFERENCE, KOLKATA 2019
• Anaplastic lymphoma kinase positive advanced nsclc: an institutional experience -ISMPOCON JAIPUR 2018

Publications :

• Trastuzumab-Related Cardiotoxicity in Adjuvant Setting: A Real-World Scenario
• Comparison of weekly cisplatin with three weekly cisplatin with concurrent radiation in locally advanced head and neck cancers, ASIAN PACIFIC JOURNAL OF HEALTH SCIENCES 2016
• Trastuzumab related cardiotoxicity in adjuvant setting: a real-world scenario, accepted for publication in SOUTH ASIAN JOURNAL OF CANCER
• Comparison of weekly cisplatin with three weekly cisplatin with concurrent radiation in locally advanced head and neck cancers

Memberships :

• Member, European Society of Medical Oncology (ESMO)
• Member, Association of Radiation Oncologists of India (AROI)